1-15 of 15
Namiki Izumi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Subject Area:
High Impact Articles in Gastroenterology , Gastroenterology , Oncology
Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, Kaoru Tsuchiya, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Naoshi Nishida, Chikara Ogawa, Tetsu Tomonari, Noriaki Nakamura, Hidekatsu Kuroda, Atsushi Takebe, Yoshifumi Takeyama, Masaaki Hidaka, Susumu Eguchi, Stephen L Chan, Masayuki Kurosaki, Namiki Izumi
Journal: Liver Cancer
Liver Cancer (2023) 12 (4): 321–338.
https://doi.org/10.1159/000529574
Published Online: 07 February 2023
View article titled, Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
Open the PDF for Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study in another window
Journal Articles

Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma

Subject Area:
High Impact Articles in Gastroenterology , Gastroenterology , Oncology
Shoji Kubo, Hiroji Shinkawa, Yoshinari Asaoka, Tatsuya Ioka, Hiroshi Igaki, Namiki Izumi, Takao Itoi, Michiaki Unno, Masayuki Ohtsuka, Takuji Okusaka, Masumi Kadoya, Masatoshi Kudo, Takashi Kumada, Norihiro Kokudo, Michiie Sakamoto, Yoshihiro Sakamoto, Hideyuki Sakurai, Tadatoshi Takayama, Osamu Nakashima, Yasushi Nagata, Etsuro Hatano, Kenichi Harada, Takamichi Murakami, Masakazu Yamamoto
Journal: Liver Cancer
Liver Cancer (2022) 11 (4): 290–314.
https://doi.org/10.1159/000522403
Published Online: 23 February 2022
View article titled, Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma
Open the PDF for Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma in another window
Journal Articles

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda, Takuji Torimura, Nobukazu Tanabe, Hiroshi Aikata, Namiki Izumi, Takahiro Yamasaki, Shunsuke Nojiri, Keisuke Hino, Hidetaka Tsumura, Teiji Kuzuya, Norio Isoda, Michihisa Moriguchi, Hajime Aino, Akio Ido, Naoto Kawabe, Kazuhiko Nakao, Yoshiyuki Wada, Sadahisa Ogasawara, Kenichi Yoshimura, Takuji Okusaka, Junji Furuse, Norihiro Kokudo, Kiwamu Okita, Philip James Johnson, Yasuaki Arai, on behalf of the TACTICS Study Group
Journal: Liver Cancer
Liver Cancer (2022) 11 (4): 354–367.
https://doi.org/10.1159/000522547
Published Online: 10 February 2022
View article titled, Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma
Open the PDF for Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma in another window
Journal Articles

Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial)

Subject Area:
Gastroenterology , Oncology
Tadatoshi Takayama, Kiyoshi Hasegawa, Namiki Izumi, Masatoshi Kudo, Mitsuo Shimada, Naoki Yamanaka, Masafumi Inomata, Shuichi Kaneko, Hisashi Nakayama, Yoshikuni Kawaguchi, Kosuke Kashiwabara, Ryosuke Tateishi, Shuichiro Shiina, Kazuhiko Koike, Yutaka Matsuyama, Masao Omata, Masatoshi Makuuchi, Norihiro Kokudo
Journal: Liver Cancer
Liver Cancer (2022) 11 (3): 209–218.
https://doi.org/10.1159/000521665
Published Online: 29 December 2021
View article titled, Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial)
Open the PDF for Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial) in another window
Journal Articles

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Yusuke Kawamura, Kiyoshi Hasegawa, Ryosuke Tateishi, Kazuya Kariyama, Shuichiro Shiina, Hidenori Toyoda, Yasuharu Imai, Atsushi Hiraoka, Masafumi Ikeda, Namiki Izumi, Michihisa Moriguchi, Sadahisa Ogasawara, Yasunori Minami, Kazuomi Ueshima, Takamichi Murakami, Shiro Miyayama, Osamu Nakashima, Hirohisa Yano, Michiie Sakamoto, Etsuro Hatano, Mitsuo Shimada, Norihiro Kokudo, Satoshi Mochida, Tetsuo Takehara, HCC Expert Panel of the Japan Society of Hepatology
Journal: Liver Cancer
Liver Cancer (2021) 10 (3): 181–223.
https://doi.org/10.1159/000514174
Published Online: 19 May 2021
View article titled, Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
Open the PDF for Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update in another window
Journal Articles

Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Kazuomi Ueshima, Sadahisa Ogasawara, Masafumi Ikeda, Yutaka Yasui, Takeshi Terashima, Tatsuya Yamashita, Shuntaro Obi, Shinpei Sato, Hiroshi Aikata, Takumi Ohmura, Hidekatsu Kuroda, Takamasa Ohki, Kengo Nagashima, Yoshihiko Ooka, Masahiro Takita, Masayuki Kurosaki, Kazuaki Chayama, Shuichi Kaneko, Namiki Izumi, Naoya Kato, Masatoshi Kudo, Masao Omata
Journal: Liver Cancer
Liver Cancer (2020) 9 (5): 583–595.
https://doi.org/10.1159/000508724
Published Online: 24 July 2020
View article titled, Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Open the PDF for Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma in another window
Journal Articles

Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma

Subject Area:
Gastroenterology , Oncology
Angel Alsina, Masatoshi Kudo, Arndt Vogel, Ann-Lii Cheng, Won Young Tak, Baek-Yeol Ryoo, Thomas R. Jeffry Evans, Carlos López López, Bruno Daniele, Soamnauth Misir, Min Ren, Namiki Izumi, Shukui Qin, Richard S. Finn
Journal: Liver Cancer
Liver Cancer (2020) 9 (1): 93–104.
https://doi.org/10.1159/000504624
Published Online: 16 December 2019
View article titled, Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma
Open the PDF for Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma in another window
Journal Articles

Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Kazuomi Ueshima, Yasutaka Chiba, Sadahisa Ogasawara, Shuntaro Obi, Namiki Izumi, Hiroshi Aikata, Hiroaki Nagano, Etsuro Hatano, Yutaka Sasaki, Keisuke Hino, Takashi Kumada, Kazuhide Yamamoto, Yasuharu Imai, Shouta Iwadou, Chikara Ogawa, Takuji Okusaka, Fumihiko Kanai, Yasuaki Arai
Journal: Liver Cancer
Liver Cancer (2019) 8 (6): 505–519.
https://doi.org/10.1159/000503032
Published Online: 08 October 2019
View article titled, Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial
Open the PDF for Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial in another window
Journal Articles

B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Kazuomi Ueshima, Yukio Osaki, Masashi Hirooka, Yasuharu Imai, Kazunobu Aso, Kazushi Numata, Masayuki Kitano, Takashi Kumada, Namiki Izumi, Yasukiyo Sumino, Chikara Ogawa, Kohei Akazawa, for the SELECTED Study Group, Japan
Journal: Liver Cancer
Liver Cancer (2019) 8 (4): 271–280.
https://doi.org/10.1159/000501082
Published Online: 06 June 2019
View article titled, B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial
Open the PDF for B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial in another window
Journal Articles

Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan

Subject Area:
Gastroenterology , Oncology
Atsushi Hiraoka, Kojiro Michitaka, Takashi Kumada, Namiki Izumi, Masumi Kadoya, Norihiro Kokudo, Shoji Kubo, Yutaka Matsuyama, Osamu Nakashima, Michiie Sakamoto, Tadatoshi Takayama, Takashi Kokudo, Kosuke Kashiwabara, Susumu Eguchi, Tatsuya Yamashita, Masatoshi Kudo, The Liver Cancer Study Group of Japan
Journal: Liver Cancer
Liver Cancer (2019) 8 (5): 403–411.
https://doi.org/10.1159/000495944
Published Online: 18 February 2019
View article titled, Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan
Open the PDF for Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan in another window
Journal Articles

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function

Subject Area:
Gastroenterology , Oncology
Atsushi Hiraoka, Kojiro Michitaka, Takashi Kumada, Namiki Izumi, Masumi Kadoya, Norihiro Kokudo, Shoji Kubo, Yutaka Matsuyama, Osamu Nakashima, Michiie Sakamoto, Tadatoshi Takayama, Takashi Kokudo, Kosuke Kashiwabara, Masatoshi Kudo, The Liver Cancer Study Group of Japan
Journal: Liver Cancer
Liver Cancer (2017) 6 (4): 325–336.
https://doi.org/10.1159/000479984
Published Online: 22 September 2017
View article titled, Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function
Open the PDF for Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function in another window
Journal Articles

Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment

Subject Area:
Gastroenterology , Oncology
Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, Yutaka Yasui, Mayu Higuchi, Tsubasa Yoshida, Yasuyuki Komiyama, Kenta Takaura, Tsuguru Hayashi, Konomi Kuwabara, Natsuko Nakakuki, Hitomi Takada, Masako Ueda, Nobuharu Tamaki, Shoko Suzuki, Jun Itakura, Yuka Takahashi, Namiki Izumi
Journal: Liver Cancer
Liver Cancer (2016) 5 (4): 257–268.
https://doi.org/10.1159/000449337
Published Online: 14 September 2016
View article titled, Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment
Open the PDF for Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib Treatment in another window
Journal Articles

Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Namiki Izumi, Michiie Sakamoto, Yutaka Matsuyama, Takafumi Ichida, Osamu Nakashima, Osamu Matsui, Yonson Ku, Norihiro Kokudo, Masatoshi Makuuchi, for the Liver Cancer Study Group of Japan
Journal: Liver Cancer
Liver Cancer (2016) 5 (3): 190–197.
https://doi.org/10.1159/000367775
Published Online: 10 May 2016
View article titled, Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
Open the PDF for Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan in another window
Journal Articles

Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

Subject Area:
Gastroenterology , Oncology
Satoshi Kitai, Masatoshi Kudo, Naoshi Nishida, Namiki Izumi, Michiie Sakamoto, Yutaka Matsuyama, Takafumi Ichida, Osamu Nakashima, Osamu Matsui, Yonson Ku, Norihiro Kokudo, Masatoshi Makuuchi, for the Liver Cancer Study Group of Japan
Journal: Liver Cancer
Liver Cancer (2016) 5 (3): 175–189.
https://doi.org/10.1159/000367765
Published Online: 03 May 2016
View article titled, Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis
Open the PDF for Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis in another window
Journal Articles

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Subject Area:
Gastroenterology , Oncology
Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai, Takuji Okusaka, Shiro Miyayama, Kaoru Tsuchiya, Kazuomi Ueshima, Atsushi Hiraoka, Masafumi Ikeda, Sadahisa Ogasawara, Tatsuya Yamashita, Tetsuya Minami, Koichiro Yamakado, on behalf of the Liver Cancer Study Group of Japan
Journal: Liver Cancer
Liver Cancer (2014) 3 (3-4): 458–468.
https://doi.org/10.1159/000343875
Published Online: 13 October 2014
View article titled, JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
Open the PDF for JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan in another window